First Citizens Bank & Trust Co. Takes Position in agilon health, inc. (NYSE:AGL)

First Citizens Bank & Trust Co. purchased a new stake in shares of agilon health, inc. (NYSE:AGL) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 24,117 shares of the company’s stock, valued at approximately $46,000.

A number of other institutional investors have also made changes to their positions in AGL. Inspire Investing LLC lifted its position in shares of agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after purchasing an additional 112,241 shares in the last quarter. Oak Thistle LLC acquired a new position in shares of agilon health during the 4th quarter worth about $25,000. Pines Wealth Management LLC bought a new stake in agilon health in the fourth quarter valued at approximately $51,000. JPMorgan Chase & Co. raised its position in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after purchasing an additional 1,083,492 shares during the period. Finally, Virtu Financial LLC acquired a new position in shares of agilon health in the third quarter valued at approximately $120,000.

Insider Activity

In other news, Director Diana Mckenzie acquired 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the acquisition, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. The trade was a 32.20 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Karen Mcloughlin bought 25,000 shares of the business’s stock in a transaction on Friday, December 13th. The shares were acquired at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the purchase, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 90,000 shares of company stock worth $198,100 over the last three months. 3.20% of the stock is currently owned by corporate insiders.

agilon health Stock Up 3.7 %

Shares of agilon health stock opened at $3.52 on Wednesday. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a 50-day moving average of $2.34 and a 200 day moving average of $3.49. The firm has a market cap of $1.45 billion, a price-to-earnings ratio of -3.74 and a beta of 0.53.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the prior year, the firm earned ($0.06) earnings per share. As a group, sell-side analysts anticipate that agilon health, inc. will post -0.59 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Stifel Nicolaus lowered their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. Sanford C. Bernstein increased their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Barclays reduced their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Evercore ISI dropped their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Finally, Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, agilon health has an average rating of “Hold” and a consensus target price of $4.03.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.